Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition
暂无分享,去创建一个
[1] K. Klimpel,et al. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[2] Jadwiga Bienkowska,et al. Crystal structure of the anthrax lethal factor , 2001, Nature.
[3] A. Zychlinsky,et al. The induction of apoptosis by bacterial pathogens. , 1999, Annual review of microbiology.
[4] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[5] A. Filak. University of Cincinnati College of Medicine. , 2000, Academic medicine : journal of the Association of American Medical Colleges.
[6] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[7] S. Saccani,et al. p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.
[8] S. Leppla,et al. Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells. , 1989, The Journal of biological chemistry.
[9] David J. Chen,et al. RETRACTED: DNA-PKcs Is Required for Activation of Innate Immunity by Immunostimulatory DNA , 2000, Cell.
[10] P. Hanna,et al. Understanding Bacillus anthracis pathogenesis. , 1999, Trends in microbiology.
[11] K D Paull,et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.
[12] G. V. Vande Woude,et al. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Karin,et al. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. , 1998, Genes & development.
[14] A. Bridges,et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Mock,et al. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. , 2000, The Biochemical journal.
[16] H. Smith,et al. THE CHEMICAL BASIS OF THE VIRULENCE OF BACILLUS ANTHRACIS. IX. ITS AGGRESSINS AND THEIR MODE OF ACTION. , 1963, British journal of experimental pathology.
[17] John A. Young,et al. Identification of the cellular receptor for anthrax toxin , 2001, Nature.
[18] M. Karin,et al. Mammalian MAP kinase signalling cascades , 2001, Nature.
[19] Chen Dong,et al. MAP kinases in the immune response. , 2002, Annual review of immunology.
[20] S. Welkos,et al. Differences in susceptibility of inbred mice to Bacillus anthracis , 1986, Infection and immunity.
[21] David W. Anderson,et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Leppla,et al. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[23] O. Yampolskaya,et al. Quantitative Pathology of Inhalational Anthrax I: Quantitative Microscopic Findings , 2001, Modern Pathology.
[24] Y. Lai,et al. Activation of p38 mitogen‐activated protein kinase and mitochondrial Ca2+‐mediated oxidative stress are essential for the enhanced expression of grp78 induced by the protein phosphatase inhibitors okadaic acid and calyculin A , 2000, Journal of cellular biochemistry.
[25] J. Watters,et al. Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11 , 1998, Molecular microbiology.
[26] W. Reith,et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.